1304198002: Product containing precisely candesartan cilexetil 8 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing angiotensin II receptor antagonist (product)\Product containing candesartan (medicinal product)\Product containing candesartan and hydrochlorothiazide (medicinal product)\Candesartan and hydrochlorothiazide only product\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing angiotensin II receptor antagonist (product)\Product containing candesartan (medicinal product)\Product containing candesartan and hydrochlorothiazide (medicinal product)\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing angiotensin II receptor antagonist (product)\Product containing candesartan (medicinal product)\Product containing candesartan in oral dose form (medicinal product form)\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing hormone receptor antagonist (product)\Product containing angiotensin II receptor antagonist (product)\Product containing candesartan (medicinal product)\Product containing candesartan and hydrochlorothiazide (medicinal product)\Candesartan and hydrochlorothiazide only product\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing hormone receptor antagonist (product)\Product containing angiotensin II receptor antagonist (product)\Product containing candesartan (medicinal product)\Product containing candesartan and hydrochlorothiazide (medicinal product)\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by disposition (product)\Product containing hormone receptor antagonist (product)\Product containing angiotensin II receptor antagonist (product)\Product containing candesartan (medicinal product)\Product containing candesartan in oral dose form (medicinal product form)\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet

\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing candesartan (medicinal product)\Product containing candesartan and hydrochlorothiazide (medicinal product)\Candesartan and hydrochlorothiazide only product\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing candesartan (medicinal product)\Product containing candesartan and hydrochlorothiazide (medicinal product)\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing candesartan (medicinal product)\Product containing candesartan in oral dose form (medicinal product form)\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by structure\Product containing benzothiadiazine (product)\Product containing hydrochlorothiazide (medicinal product)\Product containing candesartan and hydrochlorothiazide (medicinal product)\Candesartan and hydrochlorothiazide only product\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by structure\Product containing benzothiadiazine (product)\Product containing hydrochlorothiazide (medicinal product)\Product containing candesartan and hydrochlorothiazide (medicinal product)\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by structure\Product containing benzothiadiazine (product)\Product containing hydrochlorothiazide (medicinal product)\Hydrochlorothiazide-containing product in oral dose form\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by structure\Product containing benzimidazole (product)\Product containing candesartan (medicinal product)\Product containing candesartan and hydrochlorothiazide (medicinal product)\Candesartan and hydrochlorothiazide only product\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by structure\Product containing benzimidazole (product)\Product containing candesartan (medicinal product)\Product containing candesartan and hydrochlorothiazide (medicinal product)\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Medicinal product categorized by structure\Product containing benzimidazole (product)\Product containing candesartan (medicinal product)\Product containing candesartan in oral dose form (medicinal product form)\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet

\Product manufactured as oral dose form (product)\Product containing candesartan in oral dose form (medicinal product form)\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet
\Product manufactured as oral dose form (product)\Hydrochlorothiazide-containing product in oral dose form\Candesartan- and hydrochlorothiazide-containing product in oral dose form\Candesartan and hydrochlorothiazide only product in oral dose form\Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Mar 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5309609015 Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5309610013 Product containing precisely candesartan cilexetil 8 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	Is a	Candesartan and hydrochlorothiazide only product in oral dose form	true	Inferred relationship	Some
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	Has manufactured dose form	Oral tablet	true	Inferred relationship	Some
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Some
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	Plays role	Diuretic therapeutic role	false	Inferred relationship	Some
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Candesartan cilexetil (substance)	true	Inferred relationship	Some	1
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Candesartan cilexetil (substance)	true	Inferred relationship	Some	1
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	1
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	1
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Hydrochlorothiazide (substance)	true	Inferred relationship	Some	2
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Hydrochlorothiazide (substance)	true	Inferred relationship	Some	2
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	2
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
5309609015	Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5309610013	Product containing precisely candesartan cilexetil 8 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core